Corinne Gerard Selected Research

Octreotide (Sandostatin)

6/2017	Anti-proliferative and anti-secretory effects of everolimus on human pancreatic neuroendocrine tumors primary cultures: is there any benefit from combination with somatostatin analogs?
10/2014	Pasireotide and octreotide antiproliferative effects and sst2 trafficking in human pancreatic neuroendocrine tumor cultures.
9/2007	Gs alpha overexpression and loss of Gs alpha imprinting in human somatotroph adenomas: association with tumor size and response to pharmacologic treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Corinne Gerard Research Topics

Disease

3	Neoplasms (Cancer) 06/2017 - 09/2007
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 06/2017 - 10/2014
2	Primitive Neuroectodermal Tumors (PNET) 06/2017 - 10/2014
1	Adenoma (Adenomas) 03/2011
1	Pituitary Neoplasms (Pituitary Adenoma) 03/2011
1	Growth Hormone-Secreting Pituitary Adenoma 09/2007

Drug/Important Bio-Agent (IBA)

3	Octreotide (Sandostatin)FDA LinkGeneric 06/2017 - 09/2007
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 06/2017 - 03/2011
2	pasireotideIBA 06/2017 - 10/2014
1	Everolimus FDA Link 06/2017
1	TOR Serine-Threonine KinasesIBA 06/2017
1	Chromogranin AIBA 10/2014
1	Messenger RNA (mRNA)IBA 09/2007

Therapy/Procedure

2	Therapeutics 10/2014 - 03/2011